{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T12:01:17Z","timestamp":1769256077507,"version":"3.49.0"},"reference-count":17,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/j.prp.2024.155718","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T05:41:18Z","timestamp":1731130878000},"page":"155718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Germline pathogenic variants in prostate cancer"],"prefix":"10.1016","volume":"264","author":[{"given":"Yousif M.","family":"Shakroo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"suffix":"Jr.","given":"Charles A.","family":"Seabury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth A.","family":"Iczkowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kinloch","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junqi","family":"Qian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dharam M.","family":"Ramnani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2024.155718_bib1","unstructured":"National Comprehensive Cancer Network, Prostate Cancer (Accessed 4.2024). \u3008https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/prostate.pdf\u3009."},{"issue":"Suppl 5","key":"10.1016\/j.prp.2024.155718_bib2","first-page":"S3","article-title":"Risk factors for prostate cancer","volume":"4","author":"Gann","year":"2002","journal-title":"Rev. Urol."},{"key":"10.1016\/j.prp.2024.155718_bib3","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1002\/cncr.20408","article-title":"Human prostate cancer risk factors","volume":"101","author":"Bostwick","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2024.155718_bib4","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.3390\/cancers13092154","article-title":"Germline genetics of prostate cancer: prevalence of risk variants and clinical implications for disease management","volume":"13","author":"Doan","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/j.prp.2024.155718_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/pros.24340","article-title":"Germline genetics of prostate cancer","volume":"82","author":"Khan","year":"2022","journal-title":"Prostate"},{"key":"10.1016\/j.prp.2024.155718_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa1603144","article-title":"Inherited DNA-Repair gene mutations in men with metastatic prostate cancer","volume":"375","author":"Pritchard","year":"2016","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.prp.2024.155718_bib7","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1001\/jamaoncol.2018.6760","article-title":"Prevalence of germline variants in prostate cancer and implications for current genetic testing guidelines","volume":"5","author":"Nicolosi","year":"2019","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.prp.2024.155718_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.euo.2019.12.003","article-title":"Rare germline pathogenic mutations of DNA repair genes are most strongly associated with grade group 5 prostate cancer","volume":"3","author":"Wu","year":"2020","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.prp.2024.155718_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamaoncol.2023.3482","article-title":"Germline sequencing analysis to inform clinical gene panel testing for aggressive prostate cancer","volume":"9","author":"Darst","year":"2023","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.prp.2024.155718_bib10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1200\/JCO.18.00358","article-title":"PROREPAIR-B: a prospective cohort study of the impact of germline DNA repair mutations on the outcomes of patients with metastatic castration-resistant prostate cancer","volume":"37","author":"Castro","year":"2019","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.prp.2024.155718_bib11","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1200\/PO.19.00284","article-title":"Pathogenic germline DNA repair gene and HOXB13 mutations in men with metastatic prostate cancer","author":"Boyle","year":"2020","journal-title":"JCO Precis Oncol."},{"key":"10.1016\/j.prp.2024.155718_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet. Med."},{"key":"10.1016\/j.prp.2024.155718_bib13","doi-asserted-by":"crossref","first-page":"80.e1","DOI":"10.1016\/j.urolonc.2019.09.010","article-title":"Ethnic disparities among men with prostate cancer undergoing germline testing","volume":"38","author":"Kwon","year":"2020","journal-title":"Urol. Oncol."},{"key":"10.1016\/j.prp.2024.155718_bib14","doi-asserted-by":"crossref","first-page":"428","DOI":"10.5306\/wjco.v11.i7.428","article-title":"MUTYH: not just polyposis","volume":"11","author":"Curia","year":"2020","journal-title":"World J. Clin. Oncol."},{"key":"10.1016\/j.prp.2024.155718_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2013.00018","article-title":"MUTYH DNA glycosylase: the rationale for removing undamaged bases from the DNA","volume":"4","author":"Markkanen","year":"2013","journal-title":"Front. Genet."},{"key":"10.1016\/j.prp.2024.155718_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1111\/j.1349-7006.2011.01869.x","article-title":"DNA glycosylase encoded by MUTYH functions as a molecular switch for programmed cell death under oxidative stress to suppress tumorigenesis","volume":"102","author":"Oka","year":"2011","journal-title":"Cancer Sci."},{"key":"10.1016\/j.prp.2024.155718_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/oncsis.2015.4","article-title":"Erratum: MUTYH, an adenine DNA glycosylase, mediates p53 tumor suppression via PARP-dependent cell death","volume":"4","author":"Oka","year":"2015","journal-title":"Oncogenesis"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033824006290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T17:08:55Z","timestamp":1732640935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033824006290"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,12]]},"references-count":17,"alternative-id":["S0344033824006290"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2024.155718","relation":{},"ISSN":["0344-0338"],"issn-type":[{"value":"0344-0338","type":"print"}],"subject":[],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Germline pathogenic variants in prostate cancer","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2024.155718","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier GmbH. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"155718"}}